NinePointTwo Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,184	Closed	-$262K	–	210
2022 Q1	$262K	Buy	+4,184	New	+$262K	0.07%	148